Severe Cutaneous Adverse Drug Reaction to Leflunomide: A Report of Two Cases

References

• Sevilla-Mantilla C, Ortega L, Agúndez JA, Fernández-Gutiérrez B, Ladero JM, Díaz-Rubio M. Leflunomide-induced acute hepatitis. Dig Liver Dis 2004; 36: 82–84
   PubMedGoogle Scholar
• Auer J, Hinterreiter M, Allinger S, Kirchgatterer A, Knoflach P. Severe pancytopenia after leflunomide in rheumatoid arthritis. Acta Med Austriaca 2000; 27: 131–132
   PubMedGoogle Scholar
• Kamata Y, Nara H, Kamimura T, Haneda K, Iwamoto M, Masuyama J, Okazaki H, Minota S. Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction. Intern Med 2004; 43: 1201–1204
   PubMed Web of Science ®Google Scholar
• Savage RL, Highton J, Boyd IW, Chapman P. Pneumonitis associated with leflunomide: A profile of New Zealand and Australian reports. Intern Med J 2006; 36: 162–169
   PubMed Web of Science ®Google Scholar
• Hirabayashi Y, Shimizu H, Kobayashi N, Kudo K. Leflunomide-induced pneumonitis in a patient with rheumatoid arthritis. Intern Med 2006; 45: 689–691
   PubMed Web of Science ®Google Scholar
• Bruyn GA, Jansen TL, Ten Brinke A, De Vries M, Houtman PM, van Roon EN. Cavitating pneumonia, a severe complication of leflunomide therapy in chronic polyarthritis. Rheumatology (Oxford) 2007; 46: 553–554
   PubMed Web of Science ®Google Scholar
• Ochi S, Harigai M, Mizoguchi F, Iwai H, Hagiyama H, Oka T, Miyasaka N. Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: Autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage. Mod Rheumatol 2006; 16: 316–320
   PubMedGoogle Scholar
• Suissa S, Hudson M, Ernst P. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum 2006; 54: 1435–1439
   PubMed Web of Science ®Google Scholar
• Richards BL, Spies J, McGill N, Richards GW, Vaile J, Bleasel JF, Youssef PP. Effect of leflunomide on the peripheral nerves in rheumatoid arthritis. Intern Med J 2007; 37: 101–107
   PubMed Web of Science ®Google Scholar
• Gabelle A, Antoine JC, Hillaire-Buys D, Coudeyre E, Camu W. Leflunomide-related severe axonal neuropathy. Rev Neurol (Paris) 2005; 161: 1106–1109
   PubMed Web of Science ®Google Scholar
• Kho LK, Kermode AG. Leflunomide-induced peripheral neuropathy. J Clin Neurosci 2007; 14: 179–181
   PubMed Web of Science ®Google Scholar
• Holm EA, Balslev E, Jemec GB. Vasculitis occurring during leflunomide therapy. Dermatology 2001; 203: 258–259
   PubMed Web of Science ®Google Scholar
• Braun MG, Van Rhee R, Becker-Capeller D. Development and/or increase of rheumatoid nodules in RA patients following leflunomide therapy. Z Rheumatol 2004; 63: 84–87
   PubMedGoogle Scholar
• Rozin A, Yigla M, Guralnik L, Keidar Z, Vlodavsky E, Rozenbaum M, Nahir AM, Balbir-Gurman A. Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy. Clin Rheumatol 2006; 25: 384–388
   PubMed Web of Science ®Google Scholar
• Coblyn JS, Shadick N, Helfgott S. Leflunomide-associated weight loss in rheumatoid arthritis. Arthritis Rheum 2001; 44: 1048–1051
   PubMed Web of Science ®Google Scholar
• Laborde F, Loeuille D, Chary-Valckenaere I. Life-threatening hypertriglyceridemia during leflunomide therapy in a patient with rheumatoid arthritis. Arthritis Rheum 2004; 50: 3398
   PubMed Web of Science ®Google Scholar
• Canonne-Courivaud D, Carpentier O, Dejobert Y, Hachulla E, Delaporte E. Lichenoid drug reaction to leflunomide. Ann Dermatol Venereol 2003; 130: 435–437
   PubMed Web of Science ®Google Scholar
• Rivarola de Gutierrez E, Abaca H. Photodistributed lichenoid drug eruption with rhabdomyolysis occurring during leflunomide therapy. Dermatology 2004; 208: 232–233
   PubMed Web of Science ®Google Scholar
• Teraki Y, Hitomi K, Sato Y, Hamamatsu Y, Izaki S. Leflunomide-induced toxic epidermal necrolysis. Int J Dermatol 2006; 45: 1370–1371
   PubMed Web of Science ®Google Scholar
• Shastri V, Betkerur J, Kushalappa PA, Savita TG, Parthasarathi G. Severe cutaneous adverse drug reaction to leflunomide: A report of five cases. Indian J Dermatol Venereol Leprol 2006; 72: 286–289
   PubMedGoogle Scholar
• Jakob A, Porstmann R, Rompel R. Skin ulceration after leflunomide treatment in two patients with rheumatoid arthritis. J Dtsch Dermatol Ges 2006; 4: 324–327
   PubMedGoogle Scholar
• McCoy CM. Leflunomide-associated skin ulceration. Ann Pharmacother 2002; 36: 1009–1011
   PubMed Web of Science ®Google Scholar
• Maddison P, Kiely P, Kirkham B, Lawson T, Moots R, Proudfoot D, Reece R, Scott D, Sword R, Taggart A, Thwaites C, Williams E. Leflunomide in rheumatoid arthritis: Recommendations through a process of consensus. Rheumatology (Oxford) 2005; 44: 280–286
   PubMed Web of Science ®Google Scholar
• Emery P. Leflunomide: A new DMARD for rheumatoid arthritis. Hosp Med 2000; 61: 344–347
   PubMed Web of Science ®Google Scholar
• Prakash A, Jarvis B. Leflunomide: A review of its use in active rheumatoid arthritis. Drugs 1999; 58: 1137–1164
   PubMed Web of Science ®Google Scholar
• Canonne-Courivaud D, Carpentier O, Dejobert Y, Hachulla E, Delaporte E. Lichenoid drug reaction to leflunomide. Ann Dermatol Venereol 2003; 130: 435–437
   PubMed Web of Science ®Google Scholar